[
  {
    "﻿Test": "4D Lifetest Lung Dx",
    "Company": "4D Lifetec",
    "Link": "https://4dlifetec.com/cancer-detect-test/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Lung",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "No",
    "Target (Coded)": "PBCs",
    "Genetic or Protein targets": "Immune Cells",
    "Notes": "DDS (DNA Damage sensitivity) is assesssed on peripheral blood cells?",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "In Development",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "ROCA",
    "Company": "Abcodia",
    "Link": "www.therocatest.co.uk",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Ovarian",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "No",
    "Target (Coded)": "Protein",
    "Genetic or Protein targets": " CA-125 ",
    "Notes": "To delay or prevent removal of ovaries",
    "Hidden Notes": "",
    "Requirements": "BRCA1 or BRCA2 mutation",
    "FDA Link": "",
    "USA use?": "No",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "Available by request ",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": "UK only"
  },
  {
    "﻿Test": "GemciTest",
    "Company": "Acobiom",
    "Link": "https://www.acobiom.com/en/gemcitest-first-predictive-diagnostic-test-in-pancreatic-cancer/",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Pancreatic",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "No",
    "Target (Coded)": "mRNA",
    "Genetic or Protein targets": "curated RNA panel",
    "Notes": "For Gemcitabine specifically",
    "Hidden Notes": "",
    "Requirements": "metastatic Pancreaic Adeno",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "7 days",
    "Cost": "",
    "Location": "France"
  },
  {
    "﻿Test": "ACT Monitor Colon",
    "Company": "ACT Genomics",
    "Link": "https://www.actgenomics.com/tests-professional/actmonitor-colon",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "13 genes",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "10 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "ACT Monitor Breast",
    "Company": "ACT Genomics",
    "Link": "https://www.actgenomics.com/tests-professional/actmonitor-breast",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Breast",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "8 genes",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "10 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "ACT Monitor Lung",
    "Company": "ACT Genomics",
    "Link": "https://www.actgenomics.com/tests-professional/actmonitor-lung",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Lung",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "11 genes",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "10 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "ACT Monitor Plus",
    "Company": "ACT Genomics",
    "Link": "https://actgenomics.webflow.io/tests-professional/actmonitor",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Solid Tumors",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "50 genes",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "10 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "ACT Cerebra",
    "Company": "ACT Genomics",
    "Link": "https://actgenomics.webflow.io/tests-professional/actcerebra",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Brain",
    "Fluid Type": "CSF",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "40 genes",
    "Notes": "Brain mets only (no primaries)",
    "Hidden Notes": "",
    "Requirements": "Brain met must originate from solid tumor",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "8 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "ACT Liquid PRO",
    "Company": "ACT Genomics",
    "Link": "https://www.actgenomics.com/tests-professional/actliquid",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Solid Tumors",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "532 genes, 23 fusion genes, 59 copy number variation",
    "Notes": "Gene-Based",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "7 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "PreveCol",
    "Company": "Amadix",
    "Link": "https://amadix.com/prevecol/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "Fluid Type": "Blood",
    "FDA approval": "Yes ",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "mRNA",
    "Genetic or Protein targets": "",
    "Notes": "Novel mRNA biomarkers? FDA breakthrough device approval Dec 2023",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "https://amadix.com/wp-content/uploads/2024/01/PR1_DEF_PreveCol-Breakthrough-Device_202401.pdf",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "450 euro",
    "Location": "Spain"
  },
  {
    "﻿Test": "DiagnoLung",
    "Company": "Amadix",
    "Link": "https://amadix.com/diagnolung/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Lung",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "mRNA",
    "Genetic or Protein targets": "",
    "Notes": "For use with indeterminate pulminary nodules, to identify candidates for serial CT monitoring within 2 years",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "PancreaDix",
    "Company": "Amadix",
    "Link": "https://amadix.com/pancreadix/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Pancreatic",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "mRNA",
    "Genetic or Protein targets": "",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "ADXBladder",
    "Company": "Arquer Diagnostics",
    "Link": "https://arquerdx.com/our-tests/",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Bladder",
    "Fluid Type": "Urine",
    "FDA approval": "No",
    "CLIA or CAP certification": "No",
    "Target (Coded)": "Protein",
    "Genetic or Protein targets": "MCM5 ",
    "Notes": "Urine must be processed within 48 hrs. MCM5 ELISA claimed to have NPV of 99%",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "No",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "99%",
    "Dev. Stage": "",
    "Turnaround Time ": "3 hours",
    "Cost": "",
    "Location": "England"
  },
  {
    "﻿Test": "OvaWatch",
    "Company": "Aspira Women's Health",
    "Link": "https://aspirawh.com/ovawatch/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Ovarian",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "Protein",
    "Genetic or Protein targets": "7 proteins",
    "Notes": "Single score with NPV claimed over 99%",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "99%",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Ova1Plus",
    "Company": "Aspira Women's Health",
    "Link": "https://aspirawh.com/ova1plus/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Ovarian",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "Protein",
    "Genetic or Protein targets": "7 proteins",
    "Notes": "Patients with pelvic masses who are planned for surgery",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "CNSide",
    "Company": "Biocept",
    "Link": "https://biocept.com/cnside-assay/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "CNS (Central Nervous System)",
    "Fluid Type": "CSF",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "CTC",
    "Genetic or Protein targets": "Tumor Cells in CSF",
    "Notes": "Quantifies and characterizes CSF tumor cells",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "NodifyLung",
    "Company": "Biodesix",
    "Link": "https://www.biodesix.com/our-tests/nodify-lung",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Lung",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "Protein",
    "Genetic or Protein targets": "LG3BP, C163A, 7 autoantibodies",
    "Notes": "Combination test (CDT and XL2 proteomic tests) for proteins and autoantibodies associated with tumor antigens",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "Yes (Both) ",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "5 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "IQlung",
    "Company": "Biodesix",
    "Link": "https://www.biodesix.com/our-tests/iq-lung",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Lung (Non-Small Cell)",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "52 gene panel",
    "Notes": "Combination of cfDNA test, genetic panel, also includes Host Immune Classifier (HIC) test",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "Yes (Both) ",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "3 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Boston Gene Liquid Biopsy",
    "Company": "Boston Gene",
    "Link": "https://bostongene.com/providers/bostongene-liquid-biopsy/",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "216 genes",
    "Notes": "Gene-Based (genetic panel)",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "CELLSearch",
    "Company": "Menarini Silicon Biosystems",
    "Link": "https://www.cellsearchctc.com/",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "Yes",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "CTC",
    "Genetic or Protein targets": "",
    "Notes": "CTC enumeration in peripheral blood",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "None",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "CELLSearch CMMC",
    "Company": "Menarini Silicon Biosystems",
    "Link": "https://www.siliconbiosystems.com/en-us/Oncology/Multiple-Myeloma",
    "Action (Coded)": "MRD (response)",
    "Cancer Type (Coded)": "Mult. Myeloma",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "CMMC",
    "Genetic or Protein targets": "",
    "Notes": "CMMC enumeration in peripheral blood",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "None",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Advantect",
    "Company": "ClearNote Health (Bluestar Genomics)",
    "Link": "https://www.avantect.com/avantect-test/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Pancreatic",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "",
    "Notes": "Uses 5hmC as biomarker to target DNA",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "None",
    "": "",
    "Sensitivity": "66.70%",
    "Specificity": "96.90%",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "4 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "IsoPSA",
    "Company": "Cleveland Diagnostics",
    "Link": "https://www.clevelanddx.com/isopsa-testing",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "Protein",
    "Genetic or Protein targets": "PSA",
    "Notes": "For Men over 50. Targets PSA proteins released from tumor cells",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "3 to 5 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "InsureONE",
    "Company": "ClinicalGenomics",
    "Link": "https://insuretest.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "Fluid Type": "Stool",
    "FDA approval": "Yes",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "Blood in Stool",
    "Genetic or Protein targets": "",
    "Notes": "FIT - tests for blood in stool",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "Yes (Both) ",
    "": "",
    "Sensitivity": "26.30%",
    "Specificity": "96.8-98.6%",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "14 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "UROAMP",
    "Company": "Convergent Genomics",
    "Link": "https://convergentgenomics.com/products-uroamp/",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Bladder",
    "Fluid Type": "Urine",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "60 genes",
    "Notes": "Sequences DNA in urine. Identify targets for erdafitinib + pembrolizumab",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "TruBlood",
    "Company": "Datar Cancer Genetics",
    "Link": "https://trublood360.com/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "CTC",
    "Genetic or Protein targets": "",
    "Notes": "Purifies blood then uses FICC analysis to detect CTCs",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "No",
    "Medicare/Medicaid Coverage?": "None",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": "TruBlood only in UK"
  },
  {
    "﻿Test": "RadTox",
    "Company": "DiaCarta",
    "Link": "https://www.diacarta.com/products/radtox",
    "Action (Coded)": "MRD (response)",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "",
    "Notes": "Just cfDNA whole count?",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "None",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "5 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "ColoScape",
    "Company": "DiaCarta",
    "Link": "https://www.diacartaclinicallab.com/fit-tests-diacartas-coloscape/",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "61 genes, 7 methylated markers",
    "Notes": " If FIT positive but don't want colonoscopy. Claim more sensitive than FIT test. ",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "OncUria",
    "Company": "DiaCarta",
    "Link": "https://www.diacartaclinicallab.com/oncuria/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Bladder",
    "Fluid Type": "Urine",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "Protein",
    "Genetic or Protein targets": "10 biomarkers",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Dxcover Liquid Biopsy",
    "Company": "Dxcover",
    "Link": "https://www.dxcover.com/technology",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "Yes",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "CTC",
    "Genetic or Protein targets": "spectroscopic signatures  ",
    "Notes": "Uses FITR-spectroscopy + AI comparison to detect cancer.",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "In development. Requires platform (selling strat?). Validation for additional cancers ongoing",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Prostate Cancer Test",
    "Company": "Diagnolita",
    "Link": "https://www.diagnolita.lt/en/tests/prostate-cancer-biomarker-test/",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "Fluid Type": "Urine",
    "FDA approval": "No",
    "CLIA or CAP certification": "No",
    "Target (Coded)": "(t)RNA",
    "Genetic or Protein targets": "tumor specific RNA",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "No",
    "Medicare/Medicaid Coverage?": "None",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": "Lithuania"
  },
  {
    "﻿Test": "CancerRadar",
    "Company": "EarlyDx",
    "Link": "https://earlydx.com/product/cancer-radar/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "",
    "Notes": "genome-wide DNA methylation profiling, can possibly also predict tissue or origin",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "85.90%",
    "Specificity": "97.90%",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "In Development",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "ColoPlex Plus",
    "Company": "New Day Diagnostics",
    "Link": "https://newdaydiagnostics.com/wp-content/uploads/2024/02/ColoPlex-Plus-Sell-Sheet.pdf",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "methylated SEPTIN9 gene",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "84.30%",
    "Specificity": "90.00%",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "In Development",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "ColoHealth",
    "Company": "New Day Diagnostics",
    "Link": "https://newdaydiagnostics.com/wp-content/uploads/2023/11/ColoHealthSalesSheet.pdf",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "methylated SEPTIN9 gene",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "69%",
    "Specificity": "92%",
    "PPV": "",
    "NPV": "99%",
    "Dev. Stage": "Available for purchase",
    "Turnaround Time ": "",
    "Cost": "$199 ",
    "Location": ""
  },
  {
    "﻿Test": "InSure ONE",
    "Company": "Enterix",
    "Link": "https://insuretest.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "Fluid Type": "Toilet Water",
    "FDA approval": "Yes",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "Blood in Stool",
    "Genetic or Protein targets": "",
    "Notes": "FIT - covered by most insurances 1x a year",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "Yes (Both) ",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "14 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Cologuard",
    "Company": "Exact Sciences",
    "Link": "https://www.cologuard.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "Fluid Type": "Stool",
    "FDA approval": "Yes",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "sDNA",
    "Genetic or Protein targets": "KRAS, methylated NDRG4 + BMP3",
    "Notes": "Tests for stool DNA Covered by Medicare + others for those indicated",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "https://www.accessdata.fda.gov/cdrh_docs/pdf13/p130017b.pdf",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "Yes (Both) ",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "Doctor order required",
    "Turnaround Time ": "14 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "oncoguard liver",
    "Company": "Exact Sciences",
    "Link": "https://www.oncoguardliver.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Hepatocellular Carcinoma (liver)",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "10 Methylated DNA markers and alpa-fetoprotein (AFP)",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "88%",
    "Specificity": "87%",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "Doctor order required",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "ExoDx Prostate",
    "Company": "ExomeDx",
    "Link": "https://www.exosomedx.com/patients/exodx-prostate-test",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "Fluid Type": "Urine",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "exRNA",
    "Genetic or Protein targets": "Exosome gene expression from PCA3, SPDEF, ERG ",
    "Notes": "For guidance on proceeding with biopsy",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "92%",
    "Specificity": "",
    "PPV": "",
    "NPV": "91%",
    "Dev. Stage": "Doctor order required",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "FoundationOne Liquid CDx",
    "Company": "Foundation Medicine Inc",
    "Link": "https://www.foundationmedicine.com/test/foundationone-liquid-cdx",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Solid Tumors",
    "Fluid Type": "Blood",
    "FDA approval": "Yes",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "300 genes",
    "Notes": "Broad genomic panel",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "https://www.foundationmedicine.com/sites/default/files/media/documents/2023-11/P190032_S011_F1LCDx%20Technical%20Label%5B76%5D.pdf",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "Medicare Only",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "10 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Foresight CLARITY",
    "Company": "Foresight Diagnostics ",
    "Link": "https://foresight-dx.com/technology",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "",
    "Notes": "Ultrasensitive disease burden monitoring ",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "None",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "EarlyTect Colon",
    "Company": "Genomictree",
    "Link": "https://genomictree.com/ko/products/earlytect-colon-cancer/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "Fluid Type": "Stool",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "Blood in Stool",
    "Genetic or Protein targets": "methylated syndycan-2 (SDC2)",
    "Notes": "FIT-DNA test",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "No",
    "Medicare/Medicaid Coverage?": "None",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "FDA trial coming soon",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": "South Korea"
  },
  {
    "﻿Test": "EarlyTect Lung",
    "Company": "Genomictree",
    "Link": "https://genomictree.com/ko/products/earlytect-lung-cancer/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Lung",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "methylated PCDHGA12",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "No",
    "Medicare/Medicaid Coverage?": "None",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": "South Korea"
  },
  {
    "﻿Test": "EarlyTectBladder",
    "Company": "Genomictree",
    "Link": "https://genomictree.com/ko/products/earlytect-bladder-cancer/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Bladder",
    "Fluid Type": "Urine",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "Methylated PENK",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "No",
    "Medicare/Medicaid Coverage?": "None",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": "South Korea"
  },
  {
    "﻿Test": "Giasay Prostate Cancer Test",
    "Company": "Glycanostics",
    "Link": "https://giasay.com/testy/prostata/",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "No",
    "Target (Coded)": "Protein",
    "Genetic or Protein targets": "Glycan change on proteins",
    "Notes": "Glycan change (proprietary)",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": "Slovakia"
  },
  {
    "﻿Test": "Guardant360 CDx",
    "Company": "Guardant Health",
    "Link": "https://www.guardantcomplete.com/guardant-portfolio/cdx?utm_source=google&utm_medium=search&utm_campaign=Guardant360_HCP_GGL_BRND_Brand_AWA_SEA_EXTM_US_EN%20KW%20-%20SP%20BR_ALL&utm_term=guardant%20health&utm_content=search&gad_source=1&gclid=Cj0KCQiAoKeuBhCoARIsAB4WxtdsbGLJiQDJImSnXmmcqJeZnrhFNKrhj_vAMqb887fbGNuF_WHfuxwaAnOiEALw_wcB&gclsrc=aw.ds",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "Yes",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "",
    "Notes": "Gene-based for NSCLC + breast",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "7",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "GuardantReveal",
    "Company": "Guardant Health",
    "Link": "https://www.guardantcomplete.com/guardant-portfolio/reveal?utm_source=google&utm_medium=search&utm_campaign=Guardant360_HCP_GGL_BRND_Brand_AWA_SEA_EXTM_US_EN%20KW%20-%20SP%20BR_ALL&utm_term=guardant%20health&utm_content=search&gad_source=1&gclid=Cj0KCQiAoKeuBhCoARIsAB4WxtdsbGLJiQDJImSnXmmcqJeZnrhFNKrhj_vAMqb887fbGNuF_WHfuxwaAnOiEALw_wcB&gclsrc=aw.ds",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Guardant360 Response",
    "Company": "Guardant Health",
    "Link": "https://www.guardantcomplete.com/guardant-portfolio/response?utm_source=google&utm_medium=search&utm_campaign=Guardant360_HCP_GGL_BRND_Brand_AWA_SEA_EXTM_US_EN%20KW%20-%20SP%20BR_ALL&utm_term=guardant%20health&utm_content=search&gad_source=1&gclid=Cj0KCQiAoKeuBhCoARIsAB4WxtdsbGLJiQDJImSnXmmcqJeZnrhFNKrhj_vAMqb887fbGNuF_WHfuxwaAnOiEALw_wcB&gclsrc=aw.ds",
    "Action (Coded)": "MRD (response)",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "14",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Guardant360",
    "Company": "Guardant Health",
    "Link": "https://www.guardantcomplete.com/guardant-portfolio/360?utm_source=google&utm_medium=search&utm_campaign=Guardant360_HCP_GGL_BRND_Brand_AWA_SEA_EXTM_US_EN%20KW%20-%20SP%20BR_ALL&utm_term=guardant%20health&utm_content=search&gad_source=1&gclid=Cj0KCQiAoKeuBhCoARIsAB4WxtdsbGLJiQDJImSnXmmcqJeZnrhFNKrhj_vAMqb887fbGNuF_WHfuxwaAnOiEALw_wcB&gclsrc=aw.ds",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Solid Tumors",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "",
    "Notes": "Genetic Panel (broad)",
    "Hidden Notes": "Matt always uses 360, never 360CDx, says no reason for more specific use",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "10",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Guardant SHIELD",
    "Company": "Guardant Health",
    "Link": "https://bloodbasedscreening.com",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Galleri test",
    "Company": "GRAIL",
    "Link": "https://www.galleri.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "methylation patterns",
    "Notes": "Early detection for multiple cancer types, also possibly can predict tissue/organ of origin",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "None",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "Doctor order required",
    "Turnaround Time ": "",
    "Cost": "$949 ",
    "Location": ""
  },
  {
    "﻿Test": "HelioLiver",
    "Company": "Helio Genomics",
    "Link": "https://helioliver.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Hepatocellular Carcinoma (liver)",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "tumor DNA methylation",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "Yes",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "76%",
    "Specificity": "91%",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "PancraGEN",
    "Company": "Interpace Biosciences (formerly known as Interpace Diagnostics)",
    "Link": "https://pancragen.com/how-it-works/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Pancreatic",
    "Fluid Type": "Cyst Fluid",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "KRAS and GNAS point mutations, multiple tumor supresor genes",
    "Notes": "For assessment of know pancreatic cysts. Begnin, Low risk, Moderate risk, high risk report",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "EpiPatient",
    "Company": "Labcorp",
    "Link": "https://www.labcorp.com/tests/related-documents/EpiPatient",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "Fluid Type": "Blood",
    "FDA approval": "Yes",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "methylated SEPTIN 9 gene ",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "ctDNA",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "LucenceINSIGHT",
    "Company": "Lucence",
    "Link": "https://insight.lucence.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "",
    "Notes": "Not Available in USA",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "18 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "LiquidHALLMARK",
    "Company": "Lucence",
    "Link": "https://www.lucence.com/liquid-biopsy/",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "80 gene mutations",
    "Notes": "Also testing ctRNA analysis only in US (novel)",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "LungLB Test",
    "Company": "LungLife AI",
    "Link": "https://lunglifeai.com/lunglb/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Lung",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "CTC",
    "Genetic or Protein targets": "",
    "Notes": "purifies blood then uses FISH + imaging to visualize CTCs",
    "Hidden Notes": "Validated in study Jan 24",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Mitomic Prostate Test",
    "Company": "MDNA Life Sciences",
    "Link": "https://mdnalifesciences.com/mitomic-tests/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Prostate",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "MDNA",
    "Genetic or Protein targets": "3.4 kb deletion",
    "Notes": "Measures for deletion in MDNA",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Mitomic Endometriosis Test",
    "Company": "MDNA Life Sciences",
    "Link": "https://mdnalifesciences.com/mitomic-tests/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Endometrial",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "MDNA",
    "Genetic or Protein targets": "8.7 kb deletion",
    "Notes": "Measures for deletion in MDNA",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Select mdx",
    "Company": "MDxHealth",
    "Link": "https://mdxhealth.com/select-mdx-for-physicians/",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "Fluid Type": "Urine",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "mRNA",
    "Genetic or Protein targets": "HOXC6 and DLX1",
    "Notes": "Must have abnormal PSA/DRE",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Mercy Halo Test",
    "Company": "Mercy BioAnalytics",
    "Link": "https://mercybio.com/the-mercy-halo-test/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "EV",
    "Genetic or Protein targets": "",
    "Notes": "",
    "Hidden Notes": " Claim EV > ctDNA for early detection due to EV being more stable",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "OncobiotaLUNG",
    "Company": "Micronoma",
    "Link": "https://micronoma.com/lung-cancer/",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Lung",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctmbDNA",
    "Genetic or Protein targets": "",
    "Notes": "Targets Circulating Tumor Microbial DNA",
    "Hidden Notes": "Trying to detect cancers using tumor microbiome!",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "MICheck Prostate",
    "Company": "Minomic",
    "Link": "https://minomic.com/micheck-prostate/",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "Protein",
    "Genetic or Protein targets": "Total PSA, Free PSA, HE4",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": "Australia"
  },
  {
    "﻿Test": "miR Sentinel Prostate",
    "Company": "miR Scientific",
    "Link": "https://www.mirscientific.com/mir-advantage",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Prostate",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "sncRNA",
    "Genetic or Protein targets": "",
    "Notes": "",
    "Hidden Notes": "Claim sncRNA > PSA for prostate",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "GASTROClear",
    "Company": "MiRXES",
    "Link": "https://gastroclear.mirxes.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Gastric",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "No",
    "Target (Coded)": "mRNA",
    "Genetic or Protein targets": "",
    "Notes": "Only available in Singapore",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "No",
    "Medicare/Medicaid Coverage?": "None",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": "Singapore"
  },
  {
    "﻿Test": "ClarityDx Prostate",
    "Company": "Nanostics",
    "Link": "https://www.nanosticsdx.com/clarity-dx-prostate/",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "No",
    "Target (Coded)": "Protein",
    "Genetic or Protein targets": "Total PSA, Free PSA",
    "Notes": "Must have prior digital rectal exam",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Signatera",
    "Company": "Natera",
    "Link": "https://www.natera.com/oncology/signatera-advanced-cancer-detection/patients/#pg-menu-tabs",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Solid Tumors",
    "Fluid Type": "Blood",
    "FDA approval": "",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "",
    "Notes": "Requires tissue",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "NavDx",
    "Company": "Naveris",
    "Link": "https://naveris.com/what-is-navdx/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Head/Neck",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "",
    "Notes": "Tumor Tissue Modified HPV DNA test",
    "Hidden Notes": "Interesting - hpv virus genome incorporated in shedded tumor DNA",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "InVisionFirst-Lung",
    "Company": "NeoGenomics",
    "Link": "https://neogenomics.com/invisionfirstr-lung",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Lung (Non-Small Cell)",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "37 gene mutations",
    "Notes": "Gene-Based Panel",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "7 days",
    "Cost": "",
    "Location": "EU"
  },
  {
    "﻿Test": "Galeas Bladder",
    "Company": "Nonacus",
    "Link": "https://galeas.net/galeas-bladder/",
    "Action (Coded)": "Risk Assessment ",
    "Cancer Type (Coded)": "Bladder",
    "Fluid Type": "Urine",
    "FDA approval": "No",
    "CLIA or CAP certification": "No",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "23 gene mutations",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Colox",
    "Company": "Novigenix",
    "Link": "https://novigenix.com/colox-solution/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "No",
    "Target (Coded)": "PBCs",
    "Genetic or Protein targets": "",
    "Notes": "Peripheral Blood Monocuclear cells targeted and genetically analyzed",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "14 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "LITOSEEK",
    "Company": "Novigenix",
    "Link": "https://novigenix.com/litoseek-platform/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "mRNA",
    "Genetic or Protein targets": "",
    "Notes": "Early detection and possibly immunotherapy response?",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Bladder EpiCheck",
    "Company": "Nucleix",
    "Link": "https://nucleix.com/us/bladder-epicheck/",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Bladder",
    "Fluid Type": "Urine",
    "FDA approval": "Yes",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "methylation markers",
    "Notes": "non-muscle invasive bladder cancer only",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Lung EpiCheck",
    "Company": "Nucleix",
    "Link": "https://nucleix.com/us/lung-epicheck-3/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Lung",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "methylation markers",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "OrisDX",
    "Company": "OrisDX",
    "Link": "https://www.orisdx.com/",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Mouth/Throat",
    "Fluid Type": "Saliva",
    "FDA approval": "No",
    "CLIA or CAP certification": "No",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "7 gene mutations",
    "Notes": "",
    "Hidden Notes": "oral cavity squamous cell carcinoma (most common head+neck cancer!)",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "In development",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "OncoSELECT",
    "Company": "OncoDNA",
    "Link": "https://oncodna.com/for-laboratories/liquid-biopsy-oncoselect/",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "70 gene mutations",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "5 days",
    "Cost": "",
    "Location": "Germany"
  },
  {
    "﻿Test": "4Kscore Test",
    "Company": "OPKO",
    "Link": "https://4kscore.com/",
    "Action (Coded)": "Biopsy Guidance",
    "Cancer Type (Coded)": "Prostate",
    "Fluid Type": "Blood",
    "FDA approval": "Yes",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "Protein",
    "Genetic or Protein targets": "Total PSA, Free PSA, Intact PSA, hK2",
    "Notes": "Intact PSA, hK2 proprietary to OKPO",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "doctor order required",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Cxbladder",
    "Company": "Pacific Edge Diagnostics USA",
    "Link": "https://www.cxbladder.com",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Bladder",
    "Fluid Type": "Urine",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "mRNA",
    "Genetic or Protein targets": "5 mRNA targets",
    "Notes": "cxBladder Triage + Monitor available in suite",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "Medicare Only",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "7-10 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "NeXT Personal Dx",
    "Company": "Personalis",
    "Link": "https://www.personalis.com/for-clinicians/next-personal-dx/",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "",
    "Notes": "Requires tissue and blood/saliva",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "In Development",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "PredicineBEACON",
    "Company": "Predicine",
    "Link": "https://www.predicine.com/solutions-overview/predicinebeacon/",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "",
    "Notes": "Tumor agnostic approach. Profiilng?",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "6 days",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "AdnaTest BreastCancer",
    "Company": "QIAGEN",
    "Link": "https://www.qiagen.com/us/products/discovery-and-translational-research/exosomes-ctcs/circulating-tumor-cells/adnatest-breast-cancer?catno=395012",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Breast",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "CTC",
    "Genetic or Protein targets": "CA15-3, Her2",
    "Notes": "Utilizes antibodies for cell selection and EpCAM, CA15-3, HER2 expression to detect tumor cells",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": " $1,152.00 ",
    "Location": ""
  },
  {
    "﻿Test": "AdnaTest LungCancer",
    "Company": "QIAGEN",
    "Link": "https://www.qiagen.com/us/products/discovery-and-translational-research/exosomes-ctcs/circulating-tumor-cells/adnatest-lungcancer",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Lung",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "CTC",
    "Genetic or Protein targets": "",
    "Notes": "Utilizes antibodies for cell selection",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": " $1,326.00 ",
    "Location": ""
  },
  {
    "﻿Test": "AdnaTest ColonCancer",
    "Company": "QIAGEN",
    "Link": "https://www.qiagen.com/us/products/discovery-and-translational-research/exosomes-ctcs/circulating-tumor-cells/adnatest-colon-cancer",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Colon",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "CTC",
    "Genetic or Protein targets": "CEA, EGFR",
    "Notes": "Utilizes antibodies for cell selection and EpCAM, CEA, and EGFR to detect tumor cells",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": " $1,152.00 ",
    "Location": ""
  },
  {
    "﻿Test": "AdnaTest ProstateCancer",
    "Company": "QIAGEN",
    "Link": "https://www.qiagen.com/us/products/discovery-and-translational-research/exosomes-ctcs/circulating-tumor-cells/adnatest-prostate-cancer",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Prostate",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "CTC",
    "Genetic or Protein targets": "PSMA, PSA, EFGR",
    "Notes": "Utilizes antibodies for cell selection and PSMA, PSA, and EGFR to detect tumor cells",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": " $1,152.00 ",
    "Location": ""
  },
  {
    "﻿Test": "Resolution ctDx FIRST",
    "Company": "Resolution Bioscience ",
    "Link": "https://www.resolutionbio.com/assays/Resolution-ctDx-FIRST.html",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Lung (Non-Small Cell)",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "109 genes (GFR SNVs and deletions)",
    "Notes": "Companion diagnostic for adagrasib (KRAZANTI). Also includes profiling",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Resolution ctDX Lung",
    "Company": "Resolution Bioscience ",
    "Link": "https://www.resolutionbio.com/assays/Resolution-ctDx-Lung.html",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Lung (Non-Small Cell)",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "",
    "Notes": "Specific for NSCLC actionable genes",
    "Hidden Notes": "ongoing study w/ MSK",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Aristotle",
    "Company": "StageZero Life Sciences",
    "Link": "https://www.stagezerolifesciences.com/aristotle-test.html",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "mRNA",
    "Genetic or Protein targets": "",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "doctor order required",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "ColonSentry",
    "Company": "StageZero Life Sciences",
    "Link": "https://www.stagezerolifesciences.com/colonsentry.html",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "mRNA",
    "Genetic or Protein targets": "",
    "Notes": "Patient must have no history of CRC, pre-cancerous polyps, or inflammatory bowel disease",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "doctor order required",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Signal-C",
    "Company": "Universal Diagnostics",
    "Link": "https://www.universaldx.com/multicancer-platform",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "3 methylation markers, 2 fragmentation markers",
    "Notes": "",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "54%",
    "Specificity": "92%",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "Nu-Q Cancer",
    "Company": "Volition",
    "Link": "https://volition.com/nu-q",
    "Action (Coded)": "MRD (response)",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "Circ. Nucleosomes",
    "Genetic or Protein targets": "",
    "Notes": "May require a ctDNA analysis (positive vs negative) for full interpretation",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "No",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "In Development",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": ""
  },
  {
    "﻿Test": "AlphaLiquid Screening",
    "Company": "IMBdx",
    "Link": "https://www.imbdx.com/eng/about/screening.php",
    "Action (Coded)": "Txt Guidance",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "118 genes (466kb panel)",
    "Notes": "Gene-based profiling",
    "Hidden Notes": "",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "No",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "Non-USA",
    "Turnaround Time ": "7-10 Days",
    "Cost": "",
    "Location": "South Korea"
  },
  {
    "﻿Test": "CancerDetect",
    "Company": "IMBdx",
    "Link": "https://www.imbdx.com/eng/about/detect.php",
    "Action (Coded)": "MRD (recurrance)",
    "Cancer Type (Coded)": "Colorectal (CRC)",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "ctDNA",
    "Genetic or Protein targets": "",
    "Notes": "Requires tissue!",
    "Hidden Notes": "IMBdx partnered with AstraZeneca",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "No",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "63.60%",
    "Specificity": "90.80%",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": "South Korea"
  },
  {
    "﻿Test": "CancerFind",
    "Company": "IMBdx",
    "Link": "https://www.imbdx.com/eng/about/screening.php",
    "Action (Coded)": "Early Detection",
    "Cancer Type (Coded)": "Multiple",
    "Fluid Type": "Blood",
    "FDA approval": "No",
    "CLIA or CAP certification": "Yes",
    "Target (Coded)": "cfDNA",
    "Genetic or Protein targets": "methylation patters",
    "Notes": "",
    "Hidden Notes": "Early detection with tissue of origin prediction",
    "Requirements": "",
    "FDA Link": "",
    "USA use?": "No",
    "Medicare/Medicaid Coverage?": "",
    "": "",
    "Sensitivity": "",
    "Specificity": "",
    "PPV": "",
    "NPV": "",
    "Dev. Stage": "",
    "Turnaround Time ": "",
    "Cost": "",
    "Location": "South Korea"
  }
]